The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Samsung; Sanofi; Tesaro
Speakers' Bureau - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Samsung; Sanofi; Tesaro
Research Funding - Novartis (Inst)
Expert Testimony - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Samsung; Sanofi; Tesaro
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Samsung; Sanofi; Tesaro
Evaluation of survival by ADCC status: Subgroup analysis of SB3 (Trastuzumab Biosimilar) and reference trastuzumab in patients with HER2-positive early breast cancer at three-year follow-up.
 
Xavier Pivot
No Relationships to Disclose
 
Mark D. Pegram
Employment - Loxo (I)
Honoraria - See consulting below
Consulting or Advisory Role - Daiichi Sankyo; Genentech/Roche; Macrogenics; Seagen
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Daiichi Sankyo; ERYTECH Pharma; Merus; Polyphor; Roche; Seagen
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Pique (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer; Roche
 
Diana Lüftner
No Relationships to Disclose
 
Gary H. Lyman
Stock and Other Ownership Interests - Generex Biotechnology
Consulting or Advisory Role - Agendia; Amgen; Celldex (I); G1 Therapeutics; Genomic Health; Halozyme; Helsinn Therapeutics; Janssen (I); Mylan; Partners Healthcare; Pfizer; Samsung Bioepis; Spectrum Pharmaceuticals
Research Funding - Hexal
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Speakers' Bureau - Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Igor Bondarenko
No Relationships to Disclose
 
Ye Chan Yoon
Employment - Samsung Bioepis
 
Younsoo Kim
Employment - Samsung Bioepis
 
Jae Yun Lim
Employment - Samsung Bioepis
Stock and Other Ownership Interests - Samsung Bioepis